SearcharxivSearch

arXiv subjects

Debora Jutz

Publications and source records attributed to Debora Jutz.

3 recordsLinked to original sources

Privacy-Preserving Detection of Rare Disease-Associated Cell Subsets via Secure Multi-Party Computation

The detection of rare disease-associated cell subsets from high-dimensional single-cell measurements is critical for understanding diseases such as leukaemia and viral infections. CellCnn, a convolutional neural network (CNN) designed for this task, has demonstrated the ability to identify phenotype-associated cell populations at frequencies as low as 0.01\%. Training such models reliably requires patient cohorts that are larger and more diverse than any single institution can typically assemble, and the underlying single-cell data is too sensitive to share across institutional boundaries under existing privacy regulations. We propose a secure multi-party computation (MPC) framework that enables the training and inference of CellCnn entirely on secret-shared data. This ensures that neither the participants nor the computing servers ever observe raw patient data or intermediate values. Evaluated on benchmark single-cell datasets for cytomegalovirus infection (CMV) and acute myeloid leukaemia (AML), our implementation preserves accuracy close to its plaintext counterpart while outperforming the prior privacy-preserving baseline. In contrast to earlier privacy-preserving approaches that removed components such as ReLU activations and bias terms, our method retains these key parts of the CellCnn architecture and supports accurate analysis without exposing raw patient data.

cs.CR

Diagnostic Accuracy of Open-Source Vision-Language Models on Diverse Medical Imaging Tasks

This retrospective study evaluated five VLMs (Qwen2.5, Phi-4, Gemma3, Llama3.2, and Mistral3.1) using the MedFMC dataset. This dataset includes 22,349 images from 7,461 patients encompassing chest radiography (19 disease multi-label classifications), colon pathology (tumor detection), endoscopy (colorectal lesion identification), neonatal jaundice assessment (skin color-based treatment necessity), and retinal fundoscopy (5-point diabetic retinopathy grading). Diagnostic accuracy was compared in three experimental settings: visual input only, multimodal input, and chain-of-thought reasoning. Model accuracy was assessed against ground truth labels, with statistical comparisons using bootstrapped confidence intervals (p<.05). Qwen2.5 achieved the highest accuracy for chest radiographs (90.4%) and endoscopy images (84.2%), significantly outperforming the other models (p<.001). In colon pathology, Qwen2.5 (69.0%) and Phi-4 (69.6%) performed comparably (p=.41), both significantly exceeding other VLMs (p<.001). Similarly, for neonatal jaundice assessment, Qwen2.5 (58.3%) and Phi-4 (58.1%) showed comparable leading accuracies (p=.93) significantly exceeding their counterparts (p<.001). All models struggled with retinal fundoscopy; Qwen2.5 and Gemma3 achieved the highest, albeit modest, accuracies at 18.6% (comparable, p=.99), significantly better than other tested models (p<.001). Unexpectedly, multimodal input reduced accuracy for some models and modalities, and chain-of-thought reasoning prompts also failed to improve accuracy. The open-source VLMs demonstrated promising diagnostic capabilities, particularly in chest radiograph interpretation. However, performance in complex domains such as retinal fundoscopy was limited, underscoring the need for further development and domain-specific adaptation before widespread clinical application.

eess.IV

A European Multi-Center Breast Cancer MRI Dataset

Early detection of breast cancer is critical for improving patient outcomes. While mammography remains the primary screening modality, magnetic resonance imaging (MRI) is increasingly recommended as a supplemental tool for women with dense breast tissue and those at elevated risk. However, the acquisition and interpretation of multiparametric breast MRI are time-consuming and require specialized expertise, limiting scalability in clinical practice. Artificial intelligence (AI) methods have shown promise in supporting breast MRI interpretation, but their development is hindered by the limited availability of large, diverse, and publicly accessible datasets. To address this gap, we present a publicly available, multi-centre breast MRI dataset collected across six clinical institutions in five European countries. The dataset comprises 741 examinations from women undergoing screening or diagnostic breast MRI and includes malignant, benign, and non-lesion cases. Data were acquired using heterogeneous scanners, field strengths, and acquisition protocols, reflecting real-world clinical variability. In addition, we report baseline benchmark experiments using a transformer-based model to illustrate potential use cases of the dataset and to provide reference performance for future methodological comparisons.

eess.IV